B6.Cg-Myctm1.1(MYC)Gwbk/Ieg

Status

Available to order

EMMA IDEM:06087
Citation informationRRID:IMSR_EM:06087 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Myctm1.1(MYC)Gwbk/Ieg
Alternative nameC57BL/6-J / hc-Myc
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolMyctm1.1(MYC)Gwbk
Gene/Transgene symbolMyc

Information from provider

ProviderGeorg W. Bornkamm
Provider affiliationInstitute of Experimental Genetics, GSF National Research Centre of Environment and Health
Genetic informationHumanized c-Myc mouse: targeted knock-in of the human c-MYC gene into the murine c-Myc locus. Human sequences starting at the CTG initiation codon of the first exon. A piece of mouse chromosome 15 (position 61.985.920 to 61.989.995) is replaced by a piece of human chromosome 8 (position 128.748.840 to 128.753.273).
Phenotypic informationNo obvious phenotype observed.
Breeding historyChimeric mice were backcrossed onto C57BL/6J, followed by mating to C57BL/6J cre deleter mice to remove the neomycin resistance gene. Then backcrossed to C57BL/6J to get rid of the cre deleter construct and brother-sister mating to generate a mouse homozygous for human c-MYC.
References
  • Humanized c-Myc mouse.;Lehmann Frank M, Feicht Samantha, Helm Florian, Maurberger Anna, Ladinig Camilla, Zimber-Strobl Ursula, Kühn Ralf, Mautner Josef, Gerbitz Armin, Bornkamm Georg W, ;2012;PloS one;7;e42021; 22860051
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreHelmholtz Zentrum Muenchen - German Research Center for Environmental Health (GmbH), Oberschleißheim, Germany

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased prepulse inhibition / IMPC
  • decreased body length / IMPC
  • decreased fluid intake / IMPC
  • decreased bone mineral density / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • increased startle reflex / IMPC
  • increased grip strength / IMPC
  • short tibia / IMPC
  • decreased bone mineral content / IMPC
  • abnormal bone structure / IMPC
MGI phenotypes (gene matching)
  • absent erythroid progenitor cell / MGI
  • absent common myeloid progenitor cells / MGI
  • abnormal vascular development / MGI
  • abnormal angiogenesis / MGI
  • enlarged heart / MGI
  • distended pericardium / MGI
  • decreased bone marrow cell number / MGI
  • decreased cell proliferation / MGI
  • abnormal intestine morphology / MGI
  • short tail / MGI
  • small lymphoid organs / MGI
  • enlarged spleen / MGI
  • spleen hypoplasia / MGI
  • enlarged lymph nodes / MGI
  • abnormal skeletal muscle morphology / MGI
  • open neural tube / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • cyanosis / MGI
  • abnormal vasculogenesis / MGI
  • decreased embryo size / MGI
  • abnormal embryo turning / MGI
  • abnormal placenta morphology / MGI
  • placental labyrinth hypoplasia / MGI
  • abnormal visceral yolk sac morphology / MGI
  • pale yolk sac / MGI
  • postnatal growth retardation / MGI
  • decreased white adipose tissue amount / MGI
  • reduced female fertility / MGI
  • decreased litter size / MGI
  • increased B cell derived lymphoma incidence / MGI
  • decreased tumor incidence / MGI
  • premature death / MGI
  • no abnormal phenotype detected / MGI
  • lymphoid hypoplasia / MGI
  • abnormal chorion morphology / MGI
  • no phenotypic analysis / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • embryonic growth retardation / MGI
  • spontaneous chromosome breakage / MGI
  • induced chromosome breakage / MGI
  • decreased fetal size / MGI
  • abnormal embryonic erythropoiesis / MGI
  • abnormal dorsal aorta morphology / MGI
  • abnormal small intestine crypts of Lieberkuhn morphology / MGI
  • abnormal large intestine crypts of Lieberkuhn morphology / MGI
  • increased spleen weight / MGI
  • increased B cell number / MGI
  • decreased T cell number / MGI
  • abnormal trophoblast layer morphology / MGI
  • decreased T cell proliferation / MGI
  • increased B cell proliferation / MGI
  • abnormal response to injury / MGI
  • cardiovascular system phenotype / MGI
  • immune system phenotype / MGI
  • decreased memory T cell number / MGI
  • lymph node hypoplasia / MGI
  • decreased small intestinal villus size / MGI
  • abnormal T cell receptor beta chain V(D)J recombination / MGI
  • increased B cell apoptosis / MGI
  • decreased common myeloid progenitor cell number / MGI
  • abnormal enterocyte physiology / MGI
  • abnormal enterocyte proliferation / MGI
  • decreased erythroid progenitor cell number / MGI
  • decreased birth weight / MGI
  • decreased birth body size / MGI
  • abnormal NK cell physiology / MGI
  • abnormal intestinal enteroendocrine cell morphology / MGI
  • neonatal lethality, incomplete penetrance / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • decreased fibroblast proliferation / MGI
  • absent fibroblast proliferation / MGI
  • decreased Paneth cell number / MGI

Literature references

  • Humanized c-Myc mouse.;Lehmann Frank M, Feicht Samantha, Helm Florian, Maurberger Anna, Ladinig Camilla, Zimber-Strobl Ursula, Kühn Ralf, Mautner Josef, Gerbitz Armin, Bornkamm Georg W, ;2012;PloS one;7;e42021; 22860051

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).